Document is current
Any future updates will be listed below
-
Authors
Papalamprakopoulou, Zoi
Roussos, Sotirios
Ntagianta, Elisavet
Triantafyllou, Vasiliki
Kalamitsis, George
Dharia, Arpan
Sypsa, Vana
Hatzakis, Angelos
Talal, Andrew H.
-
Funding
Funding for this research was provided by:
Kaleida Health Foundation (IHS-1507-31640)
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 20 March 2025
First Online: 10 April 2025
Declarations
:
: The study protocol was approved by the Institutional Review Boards of the Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases and the University at Buffalo. The study adhered to the Helsinki Declaration principles. We obtained written informed consent from all study eligible participants prior to their participation.
: Not applicable.
: A.H.T. received grants from Merck, Gilead, and Abbott Laboratories and has served as an advisor at Gilead, Novo Nordisk, and AbbVie. VS has received grants from Gilead and AbbVie paid to affiliated institutions, and she has served as a lecturer for Gilead and AbbVie. The remaining authors declare that they have no competing interests.
